Nifedipine 67877-0757-58
- Manufacturer
- Ascend Laboratories, Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 30, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA216067
Need to source Nifedipine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nifedipine | 30 mg/1 |
Drug Class
Dihydropyridine Calcium Channel Blocker [EPC]Calcium Channel Antagonists [MoA]Dihydropyridine Calcium Channel Blocker [EPC]
Selected Package
67877-0757-58Selected300 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-58)
Other packages for this product(3)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-01)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-05)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-757-90)